Browse Title Index


 
Issue Title
 
Vol 23, No 2 (2016) Report on a Delphi process and workshop to improve accrual to cancer clinical trials Abstract   PDF   HTML
J.A.H. Bell, L.G. Balneaves, M.T. Kelly, H. Richardson
 
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective RESEARCH AND REGULATORY ISSUES FOR INTEGRATIVE ONCOLOGY Abstract   PDF
Stephen Sagar, Raimond K.W. Wong
 
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Research in castration-resistant prostate cancer: what does the future hold? Abstract   PDF
R. J. Macfarlane, K. N. Chi
 
Vol 23, No 2 (2016) Research output and the public health burden of cancer: is there any relationship? Abstract   PDF   HTML
F.M. Patafio, S.C. Brooks, X. Wei, Y. Peng, J. Biagi, C.M. Booth
 
Vol 26, No 3 (2019) Research priorities for the pan-Canadian Oncology Symptom Triage and Remote Support practice guides: a modified nominal group consensus Abstract   PDF   HTML
L. A. Jibb, D. Stacey, M. Carley, A. Davis, I. D. Graham, E. Green, L. Jolicoeur, C. Kuziemsky, C. Ludwig, T. Truant, The COSTaRS Team
 
Vol 15, No 6 (2008) Residual cancer burden in locally advanced breast cancer: a superior tool Abstract   PDF
Zeina Ahmad Nahleh
 
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trials Abstract   PDF   HTML
G.M. O’Kane, T.A. Barnes, N.B. Leighl
 
Vol 16, No 5 (2009) Resolution of severe oncogenic hypophosphatemic osteomalacia after resection of a deeply located soft tissue tumour Details   PDF
M.K. Nusier, A.R.M. Radaideh, D. Jaradat, M.M. Abu-Kalaf,
 
Vol 26, No 4 (2019) Resource use in the last three months of life by lung cancer patients in southern Ontario Abstract   PDF   HTML
Y. Wang, A. Van Dam, M. Slaven, K. J. Ellis, J. R. Goffin, R. A. Juergens, P. M. Ellis
 
Vol 24, No 3 (2017) Resource utilization and costs of managing patients with advanced melanoma: a Canadian population-based study Abstract   PDF   HTML
F. Gwadry-Sridhar, S. Nikan, A. Hamou, S.J. Seung, T. Petrella, A.M. Joshua, S. Ernst, N. Mittmann
 
Vol 16, No 5 (2009) Response to 5-fluorouracil in metastatic extramammary Paget disease of the scrotum presenting as pancytopenia and back pain Details   PDF
K.M. Beleznay, M.A. Levesque, S. Gill
 
Vol 20, No 3 (2013) Response to Bernardi and colleagues Abstract   PDF   HTML
M. Tehfe
 
Vol 19, No 1 (2012) Response to second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer: make no assumptions Abstract   PDF   HTML
I. Karam, B. Melosky
 
Vol 20, No 6 (2013) Response to “Adenocarcinoma not otherwise specified or cribriform adenocarcinoma on dorsum of tongue?” Abstract   PDF   HTML
V. Venkatesan
 
Vol 21, No 6 (2014) Response to “Need to minimize bias when surveying patient attitudes to stopping cml treatment” Abstract   PDF   HTML
D. Sanford, R. Kyle, A. Lazo–Langner, A. Xenocostas, I. Chin–Yee, K. Howson–Jan, C.C. Hsia
 
Vol 23, No 2 (2016) Response to: Second-line treatment of non-small-cell lung cancer with wild-type EGFR status. What is the best approach? Abstract   PDF   HTML
K.A. Ma, G. Kasymjanova, V. Cohen, J. Agulnik
 
Vol 19, No 6 (2012) Response to: What is the optimal management of dysphagia in metastatic esophageal cancer? Details   PDF   HTML
W.C. Hanna, L. Ferri
 
Vol 22, No 5 (2015) Response to: “Beyond the mammography debate: a moderate perspective” Abstract   PDF   HTML
M.J. Yaffe
 
Vol 22, No 5 (2015) Response to: “Counterpoint re: ‘Mammography screening—sticking to the science’” Abstract   PDF   HTML
M.J. Yaffe
 
Vol 22, No 5 (2015) Response to: “Current definition of locally advanced breast cancer” Abstract   PDF   HTML
M. Brackstone
 
Vol 23, No 3 (2016) Response to: “Small-cell carcinoma of the genitourinary tract: a point of view” Abstract   PDF   HTML
N. Pervez
 
Vol 23, No 3 (2016) Response to: “[Miller’s] Response to: ‘Beyond the mammography debate: a moderate perspective’” Abstract   PDF   HTML
M.J. Yaffe
 
Vol 23, No 3 (2016) Response to: “[Yaffe’s] Response to: ‘Beyond the mammography debate: a moderate perspective’” Abstract   PDF   HTML
A.B. Miller
 
Vol 20, No 3 (2013) Responses by breast and prostate cancer patients to out-of-pocket costs in Newfoundland and Labrador Abstract   PDF   HTML
E. Housser, M. Mathews, J. LeMessurier, S. Young, J. Hawboldt, R. West
 
Vol 13, No 6 (2006) Retinoids, Vitamin D, Invasion, and Metastasis Details   PDF
Richard J Ablin, Erik J. Tokar, Mukta M. Webber
 
Vol 23, No 3 (2016) Retrospective analysis of the effect of CAPOX and mFOLFOX6 dose intensity on survival in colorectal patients in the adjuvant setting Abstract   PDF   HTML
A. Mamo, J. Easaw, F. Ibnshamsah, A. Baig, Y.S. Rho, T. Kavan, G. Batist, P. Kavan
 
Vol 15, No 6 (2008) RETROSPECTIVE PRACTICE REVIEW OF METASTATIC NON-SMALL CELL LUNG CANCER TREATMENT WITH SECOND-LINE ERLOTINIB Abstract   PDF
Barbara Melosky, Jason Agulnik, Hazem Assi
 
Vol 22, No 4 (2015) Revealing a cancer diagnosis to patients: attitudes of patients, families, friends, nurses, and physicians in Lebanon—results of a cross-sectional study Abstract   PDF   HTML
F. Farhat, A. Othman, G. el Baba, J. Kattan
 
Vol 26, No 2 (2019) Review of Bruton tyrosine kinase inhibitors for the treatment of relapsed or refractory mantle cell lymphoma Abstract   PDF   HTML   Supplemental Material
C. Owen, N. L. Berinstein, A. Christofides, L. H. Sehn
 
Vol 16 (2009): Renal Cell Carcinoma Supplement Review of guidelines on the treatment of metastatic renal cell carcinoma Abstract   PDF
Denis Soulieres
 
Vol 19, No 4 (2012) Right atrial metastasis of uterine leiomyosarcoma causing obstructive shock Abstract   PDF   HTML
S. K. A. Nguyen, F. Wong
 
Vol 24, No 2 (2017) Rising rates of colorectal cancer among younger Iranians: is diet to blame? Abstract   PDF   HTML
S. Hessami Arani, M.A. Kerachian
 
Vol 24, No 6 (2017) Risk and predictors of suicide in colorectal cancer patients: a Surveillance, Epidemiology, and End Results analysis Abstract   PDF   HTML
H.H. Samawi, A.A. Shaheen, P.A. Tang, D.Y.C. Heng, W.Y. Cheung, M.M. Vickers
 
Vol 26, No 2 (2019) Risk factors and a predictive nomogram for non-sentinel lymph node metastases in Chinese breast cancer patients with one or two sentinel lymph node macrometastases and mastectomy Abstract   PDF   HTML
X. Y. Wang, J. T. Wang, T. Guo, X. Y. Kong, L. Chen, J. Zhai, Y. Q. Gao, Y. Fang, J. Wang
 
Vol 19, No 3 (2012) Risk factors and early detection of breast cancer: facts, questions, and genome-based perspectives Details   PDF   HTML
D. E. Ziogas
 
Vol 21, No 5 (2014) Risk factors for locoregional recurrence after postmastectomy radiotherapy in breast cancer patients with four or more positive axillary lymph nodes Abstract   PDF   HTML
Q. Li, S. Wu, J. Zhou, J. Sun, F. Li, Q. Lin, X. Guan, H. Lin, Z. He
 
Vol 22, No 6 (2015) Risk perception and psychological morbidity in men at elevated risk for prostate cancer Abstract   PDF   HTML
A.G. Matthew, T. Davidson, S. Ochs, K.L. Currie, A. Petrella, A. Finelli
 
Vol 23, No 6 (2016) Risk stratification, treatment selection, and transplant eligibility in multiple myeloma: a qualitative study of the perspectives and self-reported practices of oncologists Abstract   PDF   HTML
T.W. LeBlanc, A. Howson, W. Turell, P. Sheldon, S.C. Locke, S.A. Tuchman, C. Gasparetto, S. Kaura, Z.M. Khan, A.P. Abernethy
 
Vol 16, No 4 (2009) RNAi and microRNA-oriented therapy in cancer: rationales, promises and challenges Details   PDF
Thomas Duchaine, Frank Slack
 
Vol 16 (2009): Renal Cell Carcinoma Supplement Role of cytokine therapy for Renal Cell Carcinoma in the era of targeted agents Abstract   PDF
Sebastien J. Hotte, Rama Koneru
 
Vol 20, No 2 (2013) Role of endolaryngeal surgery (with or without laser) compared with radiotherapy in the management of early (T1) glottic cancer: a clinical practice guideline Abstract   PDF   HTML
J. Yoo, C. Lacchetti, J.A. Hammond, R.W. Gilbert
 
Vol 21, No 4 (2014) Role of neoadjuvant therapy in the management of pancreatic cancer: is the era of biomarkerdirected therapy here? Abstract   PDF   HTML
E.V. Tsvetkova, T.R. Asmis
 
Vol 19, No 1 (2012) Role of pemetrexed in advanced non-small-cell lung cancer: meta-analysis of randomized controlled trials, with histology subgroup analysis Abstract   PDF   HTML
K. Alsaleh, C. Quinton, P. M. Ellis
 
Vol 26 (2019): Advances in Colorectal Cancer: Translating Best Evidence to Practice Role of real-world evidence in informing cancer care: lessons from colorectal cancer Abstract   PDF   HTML
A. Batra, W. Y. Cheung
 
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Role of surgery in high-risk localized prostate cancer Abstract   PDF
N. Lawrentschuk, G. Trottier, C. Kuk, A. R. Zlotta
 
Vol 18, No 5 (2011) Saccharin deemed “not hazardous” in United States and abroad Details   PDF   HTML
L.Z.G. Touyz
 
Vol 22, No 1 (2015) Safe handling of cytotoxics: guideline recommendations Abstract   PDF   HTML
A.C. Easty, N. Coakley, R. Cheng, M. Cividino, P. Savage, R. Tozer, R.E. White
 
Vol 16 (2009): Endocrine Therapy Update Supplement Safety of adjuvant endocrine therapies in hormone receptor–positive early breast cancer Abstract   PDF
S. Sehdev, G. Martin, L. Sideris, W. Lam, S. Brisson
 
Vol 15, No 1 (2008) San Antonio Breast Cancer Symposium 2007—Adjuvant endocrine therapy update: ATAC 100 highlights Details   PDF
Anil Joy
 
Vol 19 (2012): Oncology in China Saponins isolated from Asparagus induce apoptosis in human hepatoma cell line HepG2 through a mitochondrial-mediated pathway Abstract   PDF   HTML
Y. Ji, C. Ji, L. Yue, H. Xu
 
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Screening for breast cancer in 2018— what should we be doing today? Abstract   PDF   HTML
J.M. Seely, T. Alhassan
 
Vol 17, No 2 (2010) Screening for colorectal carcinoma Abstract   PDF
P. H. Gordon
 
Vol 21, No 2 (2014) Screening for distress in patients with cancer: methodologic considerations Abstract   PDF   HTML
A. Feldstain, C. Tomei, M. Bélanger, S. Lebel
 
Vol 17, No 6 (2010) Screening for hepatitis B surface antigen before chemotherapy: current practice and opportunities for improvement Abstract   PDF
R. Lee, K. Vu, C.M. Bell, L. K. Hicks
 
Vol 26, No 3 (2019) Screening for new primary cancers in patients with metastatic breast cancer: a provincial analysis of the Choosing Wisely Canada recommendations Abstract   PDF   HTML
M. Tesch, K. Laing
 
Vol 16, No 3 (2009) Screening for Prostate Cancer: Controversy? What Controversy? Abstract   PDF
Richard Ablin, Mark R. Haythorn
 
Vol 21, No 6 (2014) Screening histories and contact with physicians as determinants of cervical cancer risk in Montreal, Quebec Abstract   PDF   HTML
A.R. Spence, A. Alobaid, P. Drouin, P. Goggin, L. Gilbert, D. Provencher, P. Tousignant, J.A. Hanley, E.L. Franco
 
Vol 21, No 5 (2014) Screening mammography: the turning of the tide? Abstract   PDF   HTML
W.D. Foulkes
 
Vol 26, No 1 (2019) Secondary polycythemia in a sarcoma patient: a commentary about cediranib Abstract   PDF   HTML
A. Awan, T. Alcindor
 
Vol 19, No 1 (2012) Second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer Abstract   PDF   HTML
V. Hirsh
 
Vol 26, No 2 (2019) Second-line systemic therapies for metastatic urothelial carcinoma: a population-based cohort analysis Abstract   PDF   HTML
E. S. Tsang, C. Forbes, K. N. Chi, B. J. Eigl, S. Parimi
 
Vol 23, No 2 (2016) Second-line treatment of non-small-cell lung cancer with wild-type EGFR status. What is the best approach? Abstract   PDF   HTML
I. Elghissassi, S. Boutayeb, H. Inrhaoun, H. Mrabti, H. Errihani
 
Vol 22, No 2 (2015) Secular trends in the survival of patients with laryngeal carcinoma, 1995–2007 Abstract   PDF   HTML
S.D. MacNeil, K. Liu, S.Z. Shariff, A. Thind, E. Winquist, J. Yoo, A. Nichols, K. Fung, S. Hall, A.X. Garg
 
Vol 17, No 5 (2010) Selected abstracts submitted to the 2nd International Cancer Fatigue Symposium: Putting the Pieces Together Abstract   PDF
Various Authors
 
Vol 19, No 5 (2012) Selected abstracts submitted to the 3rd International Cancer Fatigue Symposium Details   PDF   HTML
3rd International Cancer Fatigue Symposium
 
Vol 19, No 2 (2012) Selected abstracts submitted to the Fourth International Symposium on Hereditary Breast and Ovarian Cancer Abstract   PDF   HTML
Various Authors
 
Vol 16, No 5 (2009) Selected Abstracts submitted to the Third International Symposium on Hereditary Breast and Ovarian Cancer Details   PDF
Various Authors
 
Vol 26, No 1 (2019) Selected medical interventions in women with a deleterious BRCA mutation: a population-based study in British Columbia Abstract   PDF   HTML
G. E. Hanley, J. N. McAlpine, R. Cheifetz, K. A. Schrader, M. McCullum, D. Huntsman
 
Vol 25, No 1 (2018) Self-collection for under-screened women in a National Cervical Screening Program: pilot study Abstract   PDF   HTML
M. Saville, D. Hawkes, E. Mclachlan, S. Anderson, K. Arabena
 
Vol 25, No 1 (2018) Self-sampling for cervical cancer screening: Empowering women to lead a paradigm change in cancer control Abstract   PDF   HTML
E.L. Franco
 
Vol 20, No 6 (2013) Sensitivity and specificity of the Distress Thermometer in screening for distress in long-term nasopharyngeal cancer survivors Abstract   PDF   HTML
J. Tian, J.S. Hong
 
Vol 23, No 6 (2016) Sensor-controlled scalp cooling to prevent chemotherapy-induced alopecia in female cancer patients Abstract   PDF   HTML
M.K. Fehr, J. Welter, W. Sell, R. Jung, R. Felberbaum
 
Vol 24, No 3 (2017) Sentinel node necrosis is a negative prognostic factor in patients with nasopharyngeal carcinoma: a magnetic resonance imaging study of 252 patients Abstract   PDF   HTML
L. Lu, X. Wei, Y.H. Li, W.B. Li
 
Vol 23, No 5 (2016) Serum carcinoembryonic antigen as a tumour marker in patients with endometrial cancer Abstract   PDF   HTML
Y. Hashiguchi, M. Kasai, T. Fukuda, T. Ichimura, T. Yasui, T. Sumi
 
Vol 22, No 1 (2015) Serum C-reactive protein predicts poor prognosis in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy Abstract   PDF   HTML
Y.C. Zeng, R. Wu, Y.P. Xiao, F. Chi, M. Xue, Z.Y. Zhang, R. Xing, W.Z. Zhong, S.L. Wang, X. Tian, W. Chen, J.J. Chen, L.N. Wu
 
Vol 20, No 4 (2013) Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer Abstract   PDF   HTML
F. Morgillo, F. De Vita, G. Antoniol, M. Orditura, P.P. Auriemma, M.R. Diadema, E. Lieto, B. Savastano, L. Festino, M.M. Laterza, A. Fabozzi, J. Ventriglia, A. Petrillo, F. Ciardiello, A. Barbarisi, F. Iovino
 
Vol 21, No 5 (2014) Severe gastrointestinal hemorrhage during targeted therapy for advanced breast carcinoma Abstract   PDF   HTML
H. Assi, N. Abdel-Samad
 
Vol 17, No 4 (2010) Severe Raynaud syndrome induced by adjuvant interferon alfa in metastatic melanoma Abstract   PDF
H. Husein-ElAhmed, J.L. Callejas-Rubio, R. Ortega Del Olmo, R. Rios-Fernandez, N. Ortego-Centeno
 
Vol 21, No 5 (2014) Shame, guilt, and communication in lung cancer patients and their partners Abstract   PDF   HTML
D. Dirkse, L. Lamont, Y. Li, A. Simonič, G. Bebb, J. Giese-Davis
 
Vol 18, No 4 (2011) Shaping policy: the Canadian Cancer Society and the Hormone Receptor Testing Inquiry Abstract   PDF   HTML
M. Mathews, J. Newbury, E. M. Housser
 
Vol 24, No 5 (2017) Shifting practice in definitive chemoradiation for localized esophageal cancer Abstract   PDF   HTML
X.M. Qu, J.J. Biagi, W.M. Hopman, A. Mahmud
 
Vol 24, No 5 (2017) Short-course lenalidomide plus low-dose dexamethasone in the treatment of newly diagnosed multiple myeloma— a single-centre pragmatic study Abstract   PDF   HTML
W.M. Jose, K. Pavithran, T.S. Ganesan
 
Vol 26, No 3 (2019) Should laparoscopic lymph node biopsy be the preferred diagnostic modality for isolated abdominal lymphadenopathy? Abstract   PDF   HTML   Supplemental Material
R. W.D. Gilbert, B. H. Bird, M. G. Murphy, C. J. O’Boyle
 
Vol 20, No 5 (2013) Should noncurative resection of the primary tumour be performed in patients with stage IV colorectal cancer? A systematic review and meta-analysis Abstract   PDF   HTML
S. Ahmed, R.K. Shahid, A. Leis, K. Haider, S. Kanthan, B. Reeder, P. Pahwa
 
Vol 17, No 5 (2010) Should there be a legal right to die? Abstract   PDF
D. Benatar
 
Vol 15, No 3 (2008) Single versus multiple fractions of palliative radiotherapy for bone metastases: A randomized clinical trial in Iranian patients Abstract   PDF
Farnaz Amouzegar-Hashemi, Haleh Behrouzi, Ali Kazemian, Behnam Zarpak, Peiman Haddad
 
Vol 14, No 1 (2007) Single-Agent Interleukin-2 in the Treatment of Metastatic Melanoma: A Clinical Practice Guideline Details   PDF
Teresa Petrella, Ian Quirt, Shailendra Verma, Adam Edward Haynes, Manya Charette, Kate Bak, Members of the Melanoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care
 
Vol 19, No 5 (2012) Size surprise? Tumour size, nodal status, and outcome after breast cancer Details   PDF   HTML
W.D. Foulkes
 
Vol 15, No 6 (2008) Small Molecule Bcl-2 Antagonists as Targeted Therapy in Oncology Details   PDF
Matthew Warr, G.C Shore
 
Vol 23, No 3 (2016) Small-cell carcinoma of the genitourinary tract: a point of view Abstract   PDF   HTML
N. Ismaili
 
Vol 23, No 3 (2016) Smoking behaviours of current cancer patients in Canada Abstract   PDF   HTML
J. Liu, J. Chadder, S. Fung, G. Lockwood, R. Rahal, M. Halligan, D. Mowat, H. Bryant
 
Vol 23, No 6 (2016) Socioeconomic status and lifestyle behaviours in cancer survivors: smoking and physical activity Abstract   PDF   HTML
H. Naik, X. Qiu, M. C. Brown, L. Eng, D. Pringle, M. Mahler, H. Hon, K. Tiessen, H. Thai, V. Ho, C. Gonos, R. Charow, V. Pat, M. Irwin, L. Herzog, A. Ho, W. Xu, J. Jones, D. Howell, G. Liu
 
Vol 13, No 4 (2006) Solitary bone metastasis beneath the shoulder shield: Coincidence or cause? Details   PDF
Grace Fan, Emily Sinclair, Monique Christakis, Lisa Erhlich, Judit Zubovits, Edward Chow
 
Vol 19, No 3 (2012) Solitary fibrous tumour presenting as a pedunculated lung mass with associated lung atresia: report of a case Abstract   PDF   HTML
S.K. Shah, P.A. Walker, K.G. Khalil, A.D. Irani
 
Vol 16 (2009): Renal Cell Carcinoma Supplement Sorafenib in the Management of Metastatic Renal Cell Carcinoma Abstract   PDF
Catherine Guevremont, Claudio Jeldres, Pierre I Karakiewicz, Florin I. Mija
 
Vol 26, No 2 (2019) Special supplement on Canadian cancer costing research Abstract   PDF   HTML
S. Peacock, K. K.W. Chan
 
Vol 19, No 3 (2012) Specialists’ perceptions of hereditary colorectal cancer screening in Newfoundland and Labrador Abstract   PDF   HTML
J. MacEachern, M. Mathews, J. Green, D. Pullman
 
Vol 25, No 6 (2018) Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients Abstract   PDF   HTML
F. Cavagna, A. Pontes, M. Cavagna, A. Dzik, N. F. Donadio, R. Portela, M. T. Nagai, L. H. Gebrim
 
Vol 20, No 3 (2013) Spontaneous regression of metastatic melanoma after inoculation with tetanus– diphtheria–pertussis vaccine Abstract   PDF   HTML
T. Tran, D. Burt, L. Eapen, O.R. Keller
 
Vol 15, No 6 (2008) Squamous cell carcinoma of the pancreas: Case report Details   PDF
Ahmed Al-Shehri, Sveta Silverman, Karen M. King
 
1301 - 1400 of 1709 Items << < 9 10 11 12 13 14 15 16 17 18 > >>